Everyone ages differently: Cardiovascular disease and HIV
The CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart disease, and what can be done to address it
Learn MoreApril 28, 2022
Age, altruism, or a long-term view: Why do people living with HIV get the COVID-19 vaccine?
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
Learn More
CTN study tests new drug for the first time in people living with HIV
The drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV
Learn More
New research comparing HIV medications set to change international recommendations
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Learn More
Here’s what we know about COVID-19 & HIV
Many questions remain about COVID-19 and what it means for people living with HIV. We explore the research so far
Learn More
Could Cannabis Help Prevent HIV-Related Illnesses?
Drs. Cecilia Costiniuk and Ali Jenabian During the height of the AIDS epidemic in the...
Learn More
CTN 281: Canadian Children Falling Short of UNAIDS target
Quick Take In a new publication from the EPIC4 Study (CTN 281), 73% of Canadian...
Learn More
Interpreting new international study results for the Canadian context
CTN National Director Dr. Aslam Anis was quoted in a Global News story about new findings...
Learn More